Improving access to medications for opioid use disorder treatment
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)
This study is all about finding better ways to make medications for opioid use disorder more available and effective in community addiction treatment programs, so that people struggling with this condition can get the help they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10874475 on NIH RePORTER |
What this research studies
This research focuses on enhancing the availability and effectiveness of medications for opioid use disorder (MOUD) across community addiction treatment programs. It employs a stagewise implementation approach, where strategies are introduced progressively based on the needs of each program. The study involves 72 community addiction treatment programs and aims to identify the best methods for implementing MOUD effectively. By utilizing workshops and feedback mechanisms, the research seeks to bridge the gap in treatment access and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with opioid use disorder who are seeking treatment options.
Not a fit: Patients who are not affected by opioid use disorder or those who are already receiving effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the number of treatment facilities offering effective medications for opioid use disorder, leading to better recovery outcomes for patients.
How similar studies have performed: Previous research has shown success in implementing similar strategies to improve access to addiction treatment, indicating that this approach has potential for positive outcomes.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Mcgovern, Mark P — Stanford University
- Study coordinator: Mcgovern, Mark P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.